Skip to content
Trial Eligibility
Menu

Urinary Bladder Matrix (UBM) Registry

NCT07805798

This study is recruiting at 3 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Tissue Repair
  • Soft Tissue Reconstruction
  • Wound Management
  • Pressure Ulcer (PU)
  • Necrotizing Soft Tissue Infection
  • Fournier's Gangrene
  • Pilonidal Cyst
  • Open Abdomen
  • Hidradenitis Suppurativa (HS)
  • Lower Extremity Wound
  • Incisional

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
21 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Integra LifeSciences Corporation
Last updated on ClinicalTrials.gov
November 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • HonorHealth Research Institute · Scottsdale, AZ

North Carolina · 2

  • The University of North Carolina at Chapel Hill · Chapel Hill, NC
  • Atrium Health · Charlotte, NC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.